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Mutations in R-Spondin 4 (RSPO4) Underlie Inherited
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Diana C. Blaydon3, Ju-Suk Nam4, Jeong K. Yoon4, David Peter Kelsell3 and Angela M. Christiano1,2
Recently, we reported that mutations in the R-spondin 4 (RSPO4) gene underlie inherited anonychia/
hyponychia. Here, we studied five consanguineous Pakistani families with recessive inheritance of a
combination of anonychia and hyponychia. Homozygous mutations were identified in the RSPO4 gene in all
five families. Three families had a splice site mutation at the exon 2–intron 2 boundary. One family had a 26bp
deletion encompassing the start codon, and the final family had a missense mutation changing the initiating
methionine to isoleucine. We demonstrated by in situ hybridization that Rspo4 is exclusively expressed in the
mesenchyme underlying the digit tip epithelium in the mouse at embryonic day 14.5 (e14.5). These findings
expand our understanding of the role of RSPO4 in nail development and disease.
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CASE DESCRIPTION
Congenital absence of the nails in humans is referred to as
anonychia/hyponychia congenita (OMIM 206800), a rare
autosomal-recessive condition in which the only phenotype
is the absence or severe hypoplasia of all fingernails and
toenails. Using homozygosity mapping, we recently identi-
fied a region of linkage on chromosome 20p13 and identified
a spectrum of mutations in the R-spondin 4 (RSPO4) gene in
several affected families from India, Pakistan, Finland, and
the United Kingdom (Blaydon et al., 2006). An independent
study similarly reported mutations in RSPO4 in a family with
hyponychia from Germany (Bergmann et al., 2006).
To investigate further the molecular basis of anonychia,
here we studied five consanguineous families from Pakistan
(N1–N5) that show recessive inheritance of a combination of
anonychia and hyponychia (Figure 1a–e). The five families
come from different geographic regions of Pakistan. All
patients exhibited either complete absence of the nail plate
and matrix, with only the nail bed present, or hyponychia,
with some remnants of rudimentary, fragile nail plates (Figure
1f and g). No evidence for associated anomalies of
ectodermal appendages, including hair, teeth, and sweat
glands was noted in any of the affected individuals.
MUTATION IDENTIFICATION
We obtained DNA from 55 members of the five families,
including 25 affected and 30 unaffected individuals. The
Institutional Review Board of Columbia University approved
all described studies. The study was conducted according to
Declaration of Helsinki Principles and participants gave their
written informed consent. Genomic DNA was isolated from
peripheral blood collected in EDTA-containing tubes using
the PUREGENE DNA isolation kit (Gentra System, Minnea-
polis, MN). All samples were collected after informed
consent had been obtained and in accordance with the
Institutional Review Board.
To confirm that each family was linked to chromosome
20, genotyping was first performed using the markers
D20S117, D20S199, and D20S906, which are closely
mapped to the RSPO4 gene. All anonychia families were
found to be linked for each of the three markers.
To screen for a mutation in the human RSPO4 gene, exons
1–5 and flanking splice junctions were PCR amplified from
genomic DNA. The primers used for the PCR were described
previously (Blaydon et al., 2006). After purification in
Performa DTR gel filtration cartridges (Edge Biosystems,
Gaithersburg, MD), PCR fragments were directly sequenced
by an ABI PRISM 310 automated sequencer (Applied
Biosystems, Foster City, CA) with a Big Dye terminator cycle
sequencing kit (Applied Biosystems) and the primers. Homo-
zygous mutations were identified in RSPO4 in all five
Pakistani families. Families N1, N2, and N4 have a novel
splice site mutation at the exon 2–intron 2 boundary (IVS-
1G4A), predicted to result in aberrant splicing of RSPO4
(Figure 2a). Family N3 has a 26 bp deletion, which includes
the start codon in exon 1 and is predicted to lead to
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expression of a protein lacking the first 16 amino acid
residues (Figure 2b). Family N5 has a missense mutation
changing the initiating methionine of RSPO4 to isoleucine
(M1I) (Figure 2c). Each of these mutations is predicted to
impair severely the synthesis of a functional RSPO4 protein.
Two of these mutations are novel, whereas the third (N3: -9-
þ 17del26) was previously identified in our earlier studies
(Blaydon et al., 2006, family P2). No correlation has thus far
been observed between the various mutations detected and
specific phenotypic alterations in the small number of
patients studied here and in previous studies. Figure 2d
summarizes all previously reported RSPO4 mutations from
our group and others, as well as those identified in this study.
Recently, a detailed analysis of the expression patterns of
the four Rspo family members during mouse embryogenesis
was reported (Nam et al., 2007). Interestingly, Rspo4
expression was detected from e7 to e17 by reverse transcrip-
tion-PCR on cDNA derived from mouse embryos. Whole
mount in situ hybridization during embryogenesis revealed
Rspo4 expression in the groove of the neural fold at e8.5, in
the forebrain at e9.5, and in the developing heart and limbs
from e9.5 to e10.5. From e15.5 to e17.5, Rspo4 expression
was observed in a number of tissues, with the highest level of
expression in the developing tooth and various elements of
the skeleton (Nam et al., 2007). As inferred from the
anonychia phenotype, this broad pattern of expression
suggests that in all body sites except the digit tip, the function
of Rspo4 may be compensated for by the presence of another
family member.
We have previously shown Rspo4 expression in the tip of
the digits, arising between e14.5 and e15.5 (Blaydon et al.,
2006; Nam et al., 2007). To localize the expression of Rspo4
and Rspo3 to a particular compartment in early nail
development, we performed whole mount in situ hybridiza-
tion on e14.5 mouse embryos. Digoxigenin-labeled antisense
riboprobes specific to the mouse Rspo3 and Rspo4 genes
were synthesized and in situ hybridization was performed on
the limbs of e14.5 embryos as described (Nam et al., 2007).
The stained embryos were post-fixed in 4% paraformalde-
hyde in phosphate buffered saline, and cryosectioned after
embedding in Tissue-Teks OCT compound (Fisher Scientific,
Hampton, NH). The images of sections were obtained using
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Figure 1. Anonychia in five Pakistani families. (a–e) Pedigrees representing families N1–N5 with anonychia. Affected males and females are indicated by filled
squares and circles, respectively. Double lines between figures are representative of consanguineous unions. DNA was obtained from numbered individuals in
this study. (f and g) Clinical features of inherited anonychia in the fingernails and toenails.
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Figure 2. Homozygous mutations in RSPO4 are responsible for anonychia in Pakistani families N1–N5. (a) Families N1, N2, and N4 have an IVS-1G4A
mutation at the exon 2–intron 2 boundary. (b) Family N3 has a -9-þ 17del26 mutation in exon 1. (c) Family N5 has a 3G4A (M1I) mutation in exon 1.
(d) Schematic of reported RSPO4 gene mutations. -9-þ 17del26: Pakistani P2 (Blaydon et al., 2006), Pakistani N3 (this study); 3G4A: Pakistani N5 (this study);
IVS1þ 1G4A: Pakistani P4, Irish (Blaydon et al., 2006); IVS-1G4A: English E1 (Blaydon et al., 2006); 92_93insG: German (Bergmann et al., 2006);
95–110del16: Indian In1 (Blaydon et al., 2006); 194A4G: Finnish (Blaydon et al., 2006); 218G4A: German (Bergmann et al., 2006); IVS2-1G4A: Pakistani
N1, N2, and N4 (this study); 284G4T: English E1 and E2 (Blaydon et al., 2006); 319T4C: Irish, English E2 (Blaydon et al., 2006); 353G4A: Pakistani P3
(Blaydon et al., 2006).
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an HRC Axiocam fitted onto an Axioskop2 plus microscope
(Carl Zeiss, Thornwood, NY). We demonstrate that Rspo4 is
exclusively expressed in the mesenchyme underlying the
digit tip epithelium (Figure 3b). Moreover, we show that in
comparison to Rspo3, which is expressed more intensely and
in a broader region of the digit tip (Figure 3a), Rspo4
expression is weaker and more restricted.
To extend these findings further, we next examined the
expression of Rspo4 by reverse transcription-PCR in e14.5
mouse dermis and epidermis from dorsal skin. Dissected skin
was enzymatically digested, allowing for a separation of the
epidermis from the dermis. RNA was subsequently extracted
from each dissected tissue using an RNeasy Mini Kit (Qiagen,
Valenica, CA). RNA was also extracted from adult mouse
dorsal whole skin. Reverse transcription was carried out using
oligo (dT) primer and SuperScriptTM III (Invitrogen, Carlsbad,
CA) according to the manufacturer’s instructions. The primers
mRspo4 F: 50-CAGCAGAGGCTCTTCCTCTTCATC-30 and
mRspo4 R: 50-GAGCCACAGGTCTTCCCATTGTGT-30 were
used to amplify a 326 bp product. Consistent with our in situ
hybridization results, the expression of Rspo4 was restricted
to the dermis and was not present in the epidermis (Figure
3c).
We conclude that although Rspo3 is expressed at the same
place and time as Rspo4 in the mouse digit tip, RSPO3 is
apparently not able to compensate for RSPO4 in this region in
humans, because the phenotype arises in the absence of
RSPO4 despite the presence of RSPO3. Given that RSPO3 is
located on human chromosome 6, it is not a candidate in this
form of human anonychia. In mice, Rspo3 knockouts die at
e10 due to abnormal placental development (Aoki et al.,
2007). To date, we have found no evidence for locus
heterogeneity, and all anonychia families studied thus far
are both linked to and have mutations in RSPO4 on
chromosome 20.
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Figure 3. mRspo4 expression is restricted to the dermis. (a) mRspo3 and
(b) mRspo4 are both expressed in the nail field mesenchyme at e14.5 by
in situ hybridization. (c) mRspo4 is expressed in e14.5 dermis and adult
whole skin and is not present in e14.5 epidermis, as detected by reverse
transcription-PCR. D, dermis; E, epidermis; WS, whole skin.
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